ClinicalTrials.gov
public full text
Public Domain
Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris
This is a Phase II, open-label study designed to evaluate the safety, efficacy, and immunogenicity of NM8074 in PNH patients undergoing complement-inhibitor therapy with Soliris.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy#877163
- Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression#1093170
- An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis#876009
- Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)#1162889
- Safety and Activity of Digoxin With Decitabine in Adult AML and MDS#846861
Record · ID 849373
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive